Ines Lohse

2.6k total citations
43 papers, 1.2k citations indexed

About

Ines Lohse is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ines Lohse has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ines Lohse's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Ines Lohse is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Ines Lohse collaborates with scholars based in United States, Canada and Switzerland. Ines Lohse's co-authors include Rićhard P. Hill, Delphine T. Marie‐Egyptienne, Shaun P. Brothers, David W. Hedley, Melania Pintilie, Pinjiang Cao, Claes Wahlestedt, Theodore S. Lawrence, Jessica Dennison and Ming‐Sound Tsao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ines Lohse

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ines Lohse United States 18 509 425 394 202 193 43 1.2k
Gersende Alphonse France 22 684 1.3× 336 0.8× 281 0.7× 395 2.0× 122 0.6× 43 1.2k
Annett Linge Germany 15 445 0.9× 321 0.8× 238 0.6× 160 0.8× 87 0.5× 42 893
Maria Raffaella Greco Italy 19 572 1.1× 535 1.3× 679 1.7× 123 0.6× 105 0.5× 41 1.5k
Kimberly A. Luddy United States 15 567 1.1× 478 1.1× 544 1.4× 148 0.7× 161 0.8× 26 1.5k
Emmanuel Chautard France 18 515 1.0× 274 0.6× 204 0.5× 171 0.8× 46 0.2× 39 900
Phyllis Wachsberger United States 18 683 1.3× 224 0.5× 331 0.8× 157 0.8× 127 0.7× 41 1.1k
Kasumi Tozawa Japan 10 375 0.7× 286 0.7× 182 0.5× 230 1.1× 125 0.6× 15 1.0k
Géza Sáfrány Hungary 27 777 1.5× 489 1.2× 291 0.7× 361 1.8× 148 0.8× 75 2.0k
Cholpon S. Djuzenova Germany 20 657 1.3× 182 0.4× 262 0.7× 130 0.6× 219 1.1× 41 1.1k

Countries citing papers authored by Ines Lohse

Since Specialization
Citations

This map shows the geographic impact of Ines Lohse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Lohse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Lohse more than expected).

Fields of papers citing papers by Ines Lohse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Lohse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Lohse. The network helps show where Ines Lohse may publish in the future.

Co-authorship network of co-authors of Ines Lohse

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Lohse. A scholar is included among the top collaborators of Ines Lohse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Lohse. Ines Lohse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Li, Edwin O. Chaharbakhshi, Ines Lohse, et al.. (2024). Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma. Frontiers in Oncology. 14. 1417459–1417459.
4.
Li, Luyuan, Josiane E. Eid, Wensi Tao, et al.. (2024). High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation. International Journal of Molecular Sciences. 25(23). 13003–13003.
5.
Carlson, Luke, Ines Lohse, Kurt R. Weiss, et al.. (2024). Fair AI-powered orthopedic image segmentation: addressing bias and promoting equitable healthcare. Scientific Reports. 14(1). 16105–16105. 9 indexed citations
6.
Ricciardi, Natalie, Farzaneh Modarresi, Ines Lohse, et al.. (2023). Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models. Molecular Neurobiology. 60(8). 4811–4827. 4 indexed citations
7.
Dennison, Jessica, Armando J. Mendez, Angela Szeto, et al.. (2023). Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse. Biomolecules. 13(9). 1324–1324. 4 indexed citations
8.
Dennison, Jessica, Hassan Al‐Ali, Claude‐Henry Volmar, et al.. (2022). Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers. 14(17). 4094–4094. 3 indexed citations
9.
Dennison, Jessica, Natalie Ricciardi, Ines Lohse, Claude‐Henry Volmar, & Claes Wahlestedt. (2021). Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research. Journal of Alzheimer s Disease. 80(1). 41–52. 56 indexed citations
10.
Zhu, Shoumin, Rimpi Khurana, Ines Lohse, et al.. (2021). A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. Translational Oncology. 15(1). 101260–101260. 9 indexed citations
11.
Lohse, Ines & Shaun P. Brothers. (2020). Pathogenesis and Treatment of Pancreatic Cancer Related Pain. Anticancer Research. 40(4). 1789–1796. 47 indexed citations
12.
Lohse, Ines, et al.. (2019). mRNA-to-protein translation in hypoxia. Molecular Cancer. 18(1). 49–49. 77 indexed citations
13.
Lohse, Ines, Diana J. Azzam, Hassan Al‐Ali, et al.. (2019). Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing. Anticancer Research. 39(8). 4023–4030. 12 indexed citations
14.
Lohse, Ines, Hassan Al‐Ali, Claude‐Henry Volmar, et al.. (2018). Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma. PLoS ONE. 13(9). e0203173–e0203173. 7 indexed citations
15.
Luo, Yi, Issam El Naqa, Daniel L. McShan, et al.. (2017). Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis. Radiotherapy and Oncology. 123(1). 85–92. 41 indexed citations
16.
Zhang, Qiang, Yaqing Zhang, Joshua D. Parsels, et al.. (2016). Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation. Neoplasia. 18(11). 666–673. 37 indexed citations
17.
Lohse, Ines, Keira Pereira, Stephen S. Chung, et al.. (2015). Co-Injection of patient-derived fibroblasts enhances tumor growth, stromal invasion, and epithelial-to-mesenchymal transition. 4(1). 2–2. 2 indexed citations
18.
Ernsting, Mark J., Bryan Hoang, Ines Lohse, et al.. (2015). Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. Journal of Controlled Release. 206. 122–130. 114 indexed citations
19.
Lohse, Ines, Ayelet Borgida, Melissa Cheung, et al.. (2015). BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts. British Journal of Cancer. 113(3). 425–432. 52 indexed citations
20.
Lohse, Ines, Patrick T. Reilly, & Kathrin Zaugg. (2011). The CPT1C 5′UTR Contains a Repressing Upstream Open Reading Frame That Is Regulated by Cellular Energy Availability and AMPK. PLoS ONE. 6(9). e21486–e21486. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026